Cytoskeletal-Based Survival Pathways in Myocardium
Cytoskeletal-Based Survival Pathways in Myocardium
批准号:
7564097
负责人:
Richard Vander Heide
金额:
$30.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-02 至 2009-08-31
关键词:
Acute myocardial infarctionAdenovirusesAreaBiochemicalCardiac MyocytesCaspaseCell DeathCell SurvivalCellsCellular StressCessation of lifeClinicalCytoskeletonDataDown-RegulationFocal Adhesion Kinase 1Focal AdhesionsGoalsHeartHeat Stress DisordersHeat-Shock ResponseHeatingHyperplasiaHypertrophyIn VitroIndividualInjuryInterventionIschemiaLaboratoriesLeadMediator of activation proteinMembraneMicroscopicMolecularMuscle CellsMyocardialMyocardial InfarctionMyocardiumOrgan ModelPathway interactionsPlayProcessProteinsProto-Oncogene Proteins c-aktRBL2 geneRattusReceptor ActivationRecombinantsReperfusion InjuryReperfusion TherapyRoleSeriesSignal PathwaySignal TransductionSignaling ProteinStressTestingTissuesbasecytochrome cextracellularin vivoinnovationmembermortalitymouse modelpreventreceptorresearch studyresponsestressor
中文摘要
描述(由申请人提供):保护心肌细胞免于死亡是降低心肌梗死相关死亡率的最佳方法。尽管描述了许多能够保护心肌细胞免受致命损伤的干预措施,但在临床竞技场中应用这些干预措施的潜在前景仍未实现,部分原因是缺乏对心脏对应激反应的综合理解。一个仍然知之甚少的特定领域是心肌应力是如何通过肌膜转换成单个肌细胞水平的保护信号的。我们实验室的长期目标是更好地了解在心肌细胞水平上负责心脏保护信号的细胞和分子机制。本提案的目的是证明通过基于细胞骨架的途径的信号传导可以被激活以增强心肌细胞对致死性缺血损伤的存活。粘着斑激酶(FAK)已被公认为心脏以及其他组织中细胞存活信号通路的关键介导剂。最近的数据表明,存在一个整合的信号通路,涉及FAK,细胞骨架,和其他亚细胞信号蛋白,可以放大或刺激的压力,特别是缺血/再灌注,热休克,和/或膜受体刺激。这项提议将检验心肌应激,直接或通过受体激活,放大细胞骨架为基础的信号级联,导致延长心肌细胞存活的假设。该提案的具体目的将证明:1)FAK的激活在细胞外心肌应激反应中发挥核心作用; 2)基于细胞间隙的途径的激活通过Akt的激活导致心脏保护; 3)该途径的激活发生在完整的心脏中,并可能为许多描述的心脏保护干预提供共同途径。将在一系列综合实验中利用重组腺病毒、生物化学和培养心肌细胞的显微镜分析来评估应激激活的特异性细胞存活蛋白,并将在完整心脏中使用分离的灌注大鼠和小鼠缺血性细胞死亡模型来确认。这种生存/适应途径的潜在机制的表征将增强我们对不可逆损伤的理解,并可能导致急性心肌梗死治疗的新的和创新的临床策略。
英文摘要
DESCRIPTION (provided by applicant): Protecting myocytes from death is the best way to lower the mortality associated with myocardial infarction. Despite the description of many interventions capable of protecting myocytes from lethal injury, the potential promise of applying these interventions in the clinical arena has remained unfulfilled due in part to a lack of an integrative understanding of the heart's response to stress. One specific area that remains poorly understood is how myocardial stress is transduced across the sarcolemmal membrane into a protective signal at the level of the individual myocyte. The long term goal of our laboratory is to understand better the cellular and molecular mechanism(s) responsible for cardioprotective signaling at the level of the myocyte. The goal of this proposal is to demonstrate that signaling through a cytoskeletal based pathway can be activated to enhance myocyte survival against lethal ischemic injury. Focal adhesion kinase (FAK) has become recognized as a key mediator of cell survival signaling pathways in heart as well as other tissues. Recent data has demonstrated that an integrated signaling pathway exists involving FAK, the cytoskeleton, and other subcelluar signaling proteins that can be amplified or stimulated by stress; specifically ischemia/reperfusion, heat shock, and/or membrane receptor stimulation. This proposal will test the hypothesis that myocardial stress, either directly or through receptor activation, amplifies a cytoskeletal- based signaling cascade that results in prolonged myocyte survival. Specific aims of the proposal will demonstrate that: 1) activation of FAK plays a central role in the response to extracellular myocardial stress; 2) activation of the cytoskeletal-based pathway results in cardioprotection through activation of Akt; and 3) activation of the pathway occurs in intact hearts and may provide a common pathway for many described cardioprotective interventions. The specific cell survival proteins activated by stress will be evaluated in a series of integrated experiments utilizing recombinant adenoviruses, biochemical, and microscopic analysis of cultured cardiomyocytes, and will be confirmed in intact hearts using isolated perfused rat and mouse models of ischemic cell death. Characterization of the underlying mechanism(s) of this survival/adaptive pathway will enhance our understanding of irreversible injury and may lead to new and innovative clinical strategies in the therapy of acute myocardial infarction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New methods to deliver therapeutic drugs in myocardial ischemia/reperfusion injur
-
批准号:7773180
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2010
-
负责人:Richard Vander Heide
-
依托单位:
New methods to deliver therapeutic drugs in myocardial ischemia/reperfusion injur
-
批准号:8013912
-
项目类别:
-
资助金额:$21.29万
-
财政年份:2010
-
负责人:Richard Vander Heide
-
依托单位:
Cytoskeletal-Based Survival Pathways in Myocardium
-
批准号:7338343
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2007
-
负责人:Richard Vander Heide
-
依托单位:
Cytoskeletal-Based Survival Pathways in Myocardium
-
批准号:7912525
-
项目类别:
-
资助金额:$28.4万
-
财政年份:2007
-
负责人:Richard Vander Heide
-
依托单位:
Cytoskeletal-Based Survival Pathways in Myocardium
-
批准号:7204272
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2007
-
负责人:Richard Vander Heide
-
依托单位:
SIGNAL TRANSDUCTION IN MYOCARDIAL ISCHEMIC INJURY
-
批准号:6183874
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1999
-
负责人:Richard Vander Heide
-
依托单位:
SIGNAL TRANSDUCTION IN MYOCARDIAL ISCHEMIC INJURY
-
批准号:2851823
-
项目类别:
-
资助金额:$26.44万
-
财政年份:1999
-
负责人:Richard Vander Heide
-
依托单位:
SIGNAL TRANSDUCTION IN MYOCARDIAL ISCHEMIC INJURY
-
批准号:6389808
-
项目类别:
-
资助金额:$26.25万
-
财政年份:1999
-
负责人:Richard Vander Heide
-
依托单位:
海外基金